Current landscape of clinical management for systemic light chain amyloidosis

被引：0
|
作者：
Staron, Andrew [1 ,2 ,3 ]
Sanchorawala, Vaishali [1 ,2 ,3 ]
机构：
[1] Boston Univ, Amyloidosis Ctr, Chobanian & Avedisian Sch Med, 72 East Concord St,MA K-503, Boston, MA 02118 USA
[2] Boston Med Ctr, 72 East Concord St,MA K-503, Boston, MA 02118 USA
[3] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med, Sect Hematol & Oncol, Boston, MA USA
来源：
FUTURE CARDIOLOGY | 2025年 / 21卷 / 04期
关键词：
AL amyloidosis; cardiac amyloidosis; treatment; management; supportive care; AL;
D O I：
10.1080/14796678.2025.2460392
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [21] Future directions in the clinical management of amyloid light-chain amyloidosis
    Haider, Sajjad
    Ahmad, Nisar
    Anaissie, Elias
    Driscoll, James J.
    LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2241 - 2251
  • [22] Current diagnostic and therapy of light chain amyloidosis
    Schoenland, S. O.
    Bochtler, T.
    Kristen, A. V.
    Ho, A. D.
    Hegenbart, U.
    PATHOLOGE, 2009, 30 (03): : 205 - 211
  • [23] Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis
    Vaxman, Iuliana
    Gertz, Morie
    ACTA HAEMATOLOGICA, 2019, 141 (02) : 93 - 106
  • [24] Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
    Comenzo, R. L.
    Reece, D.
    Palladini, G.
    Seldin, D.
    Sanchorawala, V.
    Landau, H.
    Falk, R.
    Wells, K.
    Solomon, A.
    Wechalekar, A.
    Zonder, J.
    Dispenzieri, A.
    Gertz, M.
    Streicher, H.
    Skinner, M.
    Kyle, R. A.
    Merlini, G.
    LEUKEMIA, 2012, 26 (11) : 2317 - 2325
  • [25] Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
    R L Comenzo
    D Reece
    G Palladini
    D Seldin
    V Sanchorawala
    H Landau
    R Falk
    K Wells
    A Solomon
    A Wechalekar
    J Zonder
    A Dispenzieri
    M Gertz
    H Streicher
    M Skinner
    R A Kyle
    G Merlini
    Leukemia, 2012, 26 : 2317 - 2325
  • [26] Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
    Rao, Rohit R.
    Yong, Wai Chung
    Wasko, Mary Chester
    CASE REPORTS IN MEDICINE, 2016, 2016
  • [27] Hereditary systemic immunoglobulin light-chain amyloidosis
    Benson, Merrill D.
    Liepnieks, Juris J.
    Kluve-Beckerman, Barbara
    BLOOD, 2015, 125 (21) : 3281 - 3286
  • [28] Systemic light chain amyloidosis: an update for treating physicians
    Merlini, Giampaolo
    Wechalekar, Ashutosh D.
    Palladini, Giovanni
    BLOOD, 2013, 121 (26) : 5124 - 5130
  • [29] Supportive Care for Patients with Systemic Light Chain Amyloidosis
    Wong, Sandy W.
    Fogaren, Teresa
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (06) : 1177 - +
  • [30] Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis
    Louwsma, Jelger
    Brunger, Anne F.
    Bijzet, Johan
    Kroesen, Bart J.
    Roeloffzen, Wilfried W. H.
    Bischof, Antje
    Kuhle, Jens
    Drost, Gea
    Lange, Fiete
    Kuks, Jan B. M.
    Gans, Reinold O. B.
    Hazenberg, Bouke P. C.
    Nienhuis, Hans L. A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (01): : 50 - 55
12345